Literature DB >> 19018724

PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics.

Bin Zhang1, Wen Xie, Matthew D Krasowski.   

Abstract

The pregnane X receptor (PXR; NR1I2), a member of the nuclear receptor superfamily, regulates the expression of drug-metabolic enzymes and transporters involved in the responses of mammals to their chemical environment. The same enzyme and transporter systems are also involved in the homeostasis of numerous endogenous chemicals. The regulatory function of PXR is implicated in normal physiology and diseases, such as drug-drug interactions, hepatic steatosis, vitamin D homeostasis, bile acids homeostasis, steroid hormones homeostasis and inflammatory bowel diseases. As such, any genetic variations of this receptor could potentially have widespread effects on the disposition of xenobiotics and endobiotics. Knowledge concerning the genetic polymorphisms of PXR may help to understand the variations in human drug response and ensure safe drug use. The correlation of PXR genetic polymorphisms with several disease conditions also suggests that this receptor may represent a valid therapeutic for hepato-intestinal disorders such as inflammatory bowel disease and primary sclerosing cholangitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19018724      PMCID: PMC2593625          DOI: 10.2217/14622416.9.11.1695

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  108 in total

1.  Evaluation of 170 xenobiotics as transactivators of human pregnane X receptor (hPXR) and correlation to known CYP3A4 drug interactions.

Authors:  Michael Sinz; Sean Kim; Zhengrong Zhu; Taosheng Chen; Monique Anthony; Kenneth Dickinson; A David Rodrigues
Journal:  Curr Drug Metab       Date:  2006-05       Impact factor: 3.731

2.  The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution.

Authors:  S A Jones; L B Moore; J L Shenk; G B Wisely; G A Hamilton; D D McKee; N C Tomkinson; E L LeCluyse; M H Lambert; T M Willson; S A Kliewer; J T Moore
Journal:  Mol Endocrinol       Date:  2000-01

Review 3.  The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways.

Authors:  S A Kliewer; J M Lehmann; M V Milburn; T M Willson
Journal:  Recent Prog Horm Res       Date:  1999

4.  Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor.

Authors:  Wen Xie; Mei-Fei Yeuh; Anna Radominska-Pandya; Simrat P S Saini; Yoichi Negishi; Bobbie Sue Bottroff; Geraldine Y Cabrera; Robert H Tukey; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

5.  A human immunodeficiency virus protease inhibitor is a novel functional inhibitor of human pregnane X receptor.

Authors:  Christine Healan-Greenberg; Jeffrey F Waring; Dale J Kempf; Eric A G Blomme; Rommel G Tirona; Richard B Kim
Journal:  Drug Metab Dispos       Date:  2007-12-20       Impact factor: 3.922

6.  The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4.

Authors:  Rommel G Tirona; Wooin Lee; Brenda F Leake; Lu-Bin Lan; Cynthia Brimer Cline; Vishal Lamba; Fereshteh Parviz; Stephen A Duncan; Yusuke Inoue; Frank J Gonzalez; Erin G Schuetz; Richard B Kim
Journal:  Nat Med       Date:  2003-01-06       Impact factor: 53.440

7.  Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes.

Authors:  J C Kolars; P Schmiedlin-Ren; J D Schuetz; C Fang; P B Watkins
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

8.  Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR.

Authors:  Michelle M Tabb; Aixu Sun; Changcheng Zhou; Felix Grün; Jody Errandi; Kimberly Romero; Hang Pham; Satoshi Inoue; Shyamali Mallick; Min Lin; Barry M Forman; Bruce Blumberg
Journal:  J Biol Chem       Date:  2003-08-14       Impact factor: 5.157

9.  Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance.

Authors:  Isabelle Dussault; Hye-Dong Yoo; Min Lin; Eric Wang; Ming Fan; Ashok K Batta; Gerald Salen; Sandra K Erickson; Barry M Forman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-04       Impact factor: 11.205

10.  Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.

Authors:  Jie Zhou; Maria Febbraio; Taira Wada; Yonggong Zhai; Ramalinga Kuruba; Jinhan He; Jung Hoon Lee; Shaheen Khadem; Songrong Ren; Song Li; Roy L Silverstein; Wen Xie
Journal:  Gastroenterology       Date:  2007-11-28       Impact factor: 22.682

View more
  52 in total

Review 1.  Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR.

Authors:  Antonia H Tolson; Hongbing Wang
Journal:  Adv Drug Deliv Rev       Date:  2010-08-17       Impact factor: 15.470

Review 2.  Pregnane xenobiotic receptors and membrane progestin receptors: role in neurosteroid-mediated motivated behaviours.

Authors:  C A Frye; C J Koonce; A A Walf
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

Review 3.  PharmGKB summary: cyclosporine and tacrolimus pathways.

Authors:  Julia M Barbarino; Christine E Staatz; Raman Venkataramanan; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2013-10       Impact factor: 2.089

4.  No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin.

Authors:  Jenni E Keskitalo; Kaisa J Kurkinen; Mikko Neuvonen; Janne T Backman; Pertti J Neuvonen; Mikko Niemi
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

5.  PXR polymorphisms and their impact on pharmacokinetics/pharmacodynamics of repaglinide in healthy Chinese volunteers.

Authors:  Qing-qing Du; Zhi-jun Wang; Lin He; Xue-hua Jiang; Ling Wang
Journal:  Eur J Clin Pharmacol       Date:  2013-06-27       Impact factor: 2.953

Review 6.  Pregnane X receptor and drug-induced liver injury.

Authors:  Yue-Ming Wang; Sergio C Chai; Christopher T Brewer; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-09-25       Impact factor: 4.481

7.  Copy Number Alterations in Tumor Genomes Deleting Antineoplastic Drug Targets Partially Compensated by Complementary Amplifications.

Authors:  Ha Vu Tran; Alexandra K Kiemer; Volkhard Helms
Journal:  Cancer Genomics Proteomics       Date:  2018 Sep-Oct       Impact factor: 4.069

8.  Role of pregnane xenobiotic receptor in the midbrain ventral tegmental area for estradiol- and 3α,5α-THP-facilitated lordosis of female rats.

Authors:  C A Frye; C J Koonce; A A Walf
Journal:  Psychopharmacology (Berl)       Date:  2014-01-17       Impact factor: 4.530

9.  Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance.

Authors:  Muriel Noetzli; Monia Guidi; Karsten Ebbing; Stephan Eyer; Laurence Wilhelm; Agnès Michon; Valérie Thomazic; Ioana Stancu; Abdel-Messieh Alnawaqil; Christophe Bula; Serge Zumbach; Michel Gaillard; Panteleimon Giannakopoulos; Armin von Gunten; Chantal Csajka; Chin B Eap
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

10.  Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications.

Authors:  Matthew D Krasowski
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.